fda's advertising and promotion requirements

FDA Scrutiny of Promotion and Advertising Practices

Philadelphia (United States), 22-23 September 2016


Key deadlines
Conference starts:
2016-09-22
Website

Visit the conference website

Conference Description

Course Description: If you go "off label" with advertising and promotion, you become embroiled in FDA's advertising and promotion requirements. For devices, the law is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments need to collaborate now more than ever before. Firms need to identify practical criteria to make marketing decisions. The big question is whether or not marketing managers and regulatory affairs managers will really try to reach common ground. FDA's Center for Devices and Radiological Health (CDRH) has never issued a comprehensive guidance on advertising and promotion. You are on your own. FDA's Center for Drug Evaluation and Research (CDER) uses long-standing regulations and a growing number of guidance documents in its regulatory approach. Policing social media has become a new regulatory responsibility. Bottom line, do you know when you are running afoul of FDA's requirements or are you guessing? Can you afford to guess? The cost to your business and the confusion left in your customer's mind becomes an unwelcomed nightmare. With this seminar you will learn how to navigate FDA's numerous legal options and how to interpret them based on basic legal principles. Applying new guidance documents becomes a new test of the FDA's legal boundaries and enforcement options. The agency now applies the principles of cognitive psychology to aid in its determination of what a message really conveys. This academic discipline may or may not get to the root of what consumers take away as the message. What is more challenging is whether a consumer's mind makes its decisions on what it learns versus pre-existing emotional factors that may or may not be conscious. This conference will provide insight on how to manage your marketing activity and gauge what regulatory risks your business is willing to accept. You will learn how corporate management requires cooperation between marketing, regulatory affairs, legal counsel, manufacturing, engineering and finance departments. You will understand that a weak link in any department leaves the entire corporation vulnerable to FDA enforcement. Most importantly, you will understand the boundaries that FDA uses and how easy it is to cross them. With information from this course, you can step back and rationally evaluate your firm's regulatory profile for advertising and promotion practices. What is not so easy is to know is how the potential customer or existing user will actually make their decision and act on it. Who will Benefit: Sales and Marketing executives and managers Regulatory Managers In-house Legal Counsel and Contract Specialists 3rtd party consultants Venture Capitalists Investors Business Acquisition Executives Owners of New or Developing Firms Own label distributors International Trade Managers Product specification developers For Registration - http://www.complianceonline.com/fda-scrutiny-promotion-advertising-practices-ftc-mass-media-doj-off-label-seminar-training-80273SEM-prdsm?channel=confroll Note: Use coupon code NB5SQH8N and get 10% off on registration.

Comments

No comments yet!

You must register or sign in to post a comment.